Recombinant Human HLA-C*03:03&B2M Monomer Protein (HEK293)，Avi & His

HLA-C*03:03 and beta-2-microglobulin (B2M) monomer recombinant proteins are key components in understanding the human immune response, particularly in the context of major histocompatibility complex (MHC) class I molecules. HLA-C is a crucial molecule involved in the presentation of peptide antigens to CD8+ T cells, thereby playing a significant role in cellular immunity. Variants like HLA-C*03:03 can influence susceptibility to various diseases, including autoimmune disorders and infections. B2M serves as an essential structural component of MHC class I molecules, stabilizing their structural integrity and facilitating their expression on the cell surface. The study of HLA-C*03:03 and B2M monomer proteins provides insights into their molecular interactions, peptide-binding mechanisms, and their potential role in disease association. Recent advancements in recombinant protein technology allow for the production of these proteins in sufficient quantities for detailed biochemical and structural studies, enabling researchers to explore their functions and implications in immunology, therapeutic interventions, and vaccine development. Understanding the specifics of HLA-C*03:03's peptide repertoire and its interaction with B2M could lead to discoveries that enhance the effectiveness of immunotherapies and improve personalized medicine approaches for patients with HLA-associated diseases.